Educational Series:  Pharmacological prevention and management of heart failure a consensus update

This publication is an educational resource summarising changes in recommendations for the management of stable heart failure, as outlined in a recent Australian Consensus Statement. Commentary by Prof Andrew Sindone.

Includes:

• treatments to prevent or delay the development of heart failure in patients with diabetic kidney disease
• the wider and earlier use of an angiotensin receptor neprilysin inhibitor (ARNI) and SGLT2 inhibitor in those with established heart failure with reduced ejection fraction
• additional therapies for those with heart failure with mildly reduced or preserved ejection fractions.